Stay updated on Pilot Trial Flecainide in ARVC Patients Clinical Trial
Sign up to get notified when there's something new on the Pilot Trial Flecainide in ARVC Patients Clinical Trial page.

Latest updates to the Pilot Trial Flecainide in ARVC Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedRevision from v3.3.1 to v3.3.2 appears as a metadata update on the page, with no evident changes to study details, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoChange DetectedPage revision history updated to v3.3.1 and v3.2.0 removed; this is a metadata-level update with no noticeable impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange Detected- Removed the government funding lapse notice banner from the page. The remainder of the study details and related information remain unchanged.SummaryDifference0.4%

- Check44 days agoChange DetectedNo significant changes detected to the study details; the page continues to present the study overview, design, eligibility criteria, outcomes, and locations.SummaryDifference0.4%

- Check73 days agoChange Detected- Updated operating status notice due to funding lapse and current open status of NIH Clinical Center; updated version to v3.2.0. - Removed old version marker v3.1.0.SummaryDifference3%

- Check80 days agoChange DetectedCore content topics on drug safety and related substandard/ counterfeit drug issues were removed, while a new version label (v3.1.0) was added.SummaryDifference0.5%

Stay in the know with updates to Pilot Trial Flecainide in ARVC Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pilot Trial Flecainide in ARVC Patients Clinical Trial page.